These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 25700953

  • 1. In vivo imaging of tau pathology using multi-parametric quantitative MRI.
    Wells JA, O'Callaghan JM, Holmes HE, Powell NM, Johnson RA, Siow B, Torrealdea F, Ismail O, Walker-Samuel S, Golay X, Rega M, Richardson S, Modat M, Cardoso MJ, Ourselin S, Schwarz AJ, Ahmed Z, Murray TK, O'Neill MJ, Collins EC, Colgan N, Lythgoe MF.
    Neuroimage; 2015 May 01; 111():369-78. PubMed ID: 25700953
    [Abstract] [Full Text] [Related]

  • 2. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.
    Sahara N, Perez PD, Lin WL, Dickson DW, Ren Y, Zeng H, Lewis J, Febo M.
    Neurobiol Aging; 2014 Jun 01; 35(6):1364-74. PubMed ID: 24411290
    [Abstract] [Full Text] [Related]

  • 3. Imaging the accumulation and suppression of tau pathology using multiparametric MRI.
    Holmes HE, Colgan N, Ismail O, Ma D, Powell NM, O'Callaghan JM, Harrison IF, Johnson RA, Murray TK, Ahmed Z, Heggenes M, Fisher A, Cardoso MJ, Modat M, Walker-Samuel S, Fisher EM, Ourselin S, O'Neill MJ, Wells JA, Collins EC, Lythgoe MF.
    Neurobiol Aging; 2016 Mar 01; 39():184-94. PubMed ID: 26923415
    [Abstract] [Full Text] [Related]

  • 4. Fluorine-19 magnetic resonance imaging probe for the detection of tau pathology in female rTg4510 mice.
    Yanagisawa D, Ibrahim NF, Taguchi H, Morikawa S, Kato T, Hirao K, Shirai N, Sogabe T, Tooyama I.
    J Neurosci Res; 2018 May 01; 96(5):841-851. PubMed ID: 29063641
    [Abstract] [Full Text] [Related]

  • 5. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
    Song L, Lu SX, Ouyang X, Melchor J, Lee J, Terracina G, Wang X, Hyde L, Hess JF, Parker EM, Zhang L.
    Mol Neurodegener; 2015 Mar 26; 10():14. PubMed ID: 25881209
    [Abstract] [Full Text] [Related]

  • 6. Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).
    Kim J, Choi IY, Duff KE, Lee P.
    Neurochem Res; 2017 Jun 26; 42(6):1649-1660. PubMed ID: 28523532
    [Abstract] [Full Text] [Related]

  • 7. Multifaceted assessment of the APP/PS1 mouse model for Alzheimer's disease: Applying MRS, DTI, and ASL.
    Shen Z, Lei J, Li X, Wang Z, Bao X, Wang R.
    Brain Res; 2018 Nov 01; 1698():114-120. PubMed ID: 30077647
    [Abstract] [Full Text] [Related]

  • 8. In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
    Snow WM, Dale R, O'Brien-Moran Z, Buist R, Peirson D, Martin M, Albensi BC.
    J Alzheimers Dis; 2017 Nov 01; 58(3):841-853. PubMed ID: 28505976
    [Abstract] [Full Text] [Related]

  • 9. Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
    Parka A, Volbracht C, Hall B, Bastlund JF, Nedergaard M, Laursen B, Botta P, Sotty F.
    J Alzheimers Dis; 2023 Nov 01; 93(1):247-262. PubMed ID: 37005884
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.
    Kim WH, Racine AM, Adluru N, Hwang SJ, Blennow K, Zetterberg H, Carlsson CM, Asthana S, Koscik RL, Johnson SC, Bendlin BB, Singh V.
    Neuroimage Clin; 2019 Nov 01; 21():101586. PubMed ID: 30502079
    [Abstract] [Full Text] [Related]

  • 11. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M, Takuwa H, Takado Y, Tokunaga M, Tsukamoto S, Minatohara K, Ono M, Seki C, Maeda J, Urushihata T, Minamihisamatsu T, Aoki I, Kawamura K, Zhang MR, Suhara T, Sahara N, Higuchi M.
    J Neurosci; 2020 Apr 22; 40(17):3491-3501. PubMed ID: 32265258
    [Abstract] [Full Text] [Related]

  • 12. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, Ances BM, Berman SB, Brosch JR, Galasko D, Gauthier S, Lah JJ, Masellis M, van Dyck CH, Mintun MA, Klein G, Ristic S, Cairns NJ, Marcus DS, Xiong C, Holtzman DM, Raichle ME, Morris JC, Bateman RJ, Benzinger TLS.
    Brain; 2019 Apr 01; 142(4):1063-1076. PubMed ID: 30753379
    [Abstract] [Full Text] [Related]

  • 13. Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease.
    Colgan N, Siow B, O'Callaghan JM, Harrison IF, Wells JA, Holmes HE, Ismail O, Richardson S, Alexander DC, Collins EC, Fisher EM, Johnson R, Schwarz AJ, Ahmed Z, O'Neill MJ, Murray TK, Zhang H, Lythgoe MF.
    Neuroimage; 2016 Jan 15; 125():739-744. PubMed ID: 26505297
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
    Endepols H, Anglada-Huguet M, Mandelkow E, Schmidt Y, Krapf P, Zlatopolskiy BD, Neumaier B, Mandelkow EM, Drzezga A.
    Mol Neurobiol; 2022 Jun 15; 59(6):3402-3413. PubMed ID: 35312967
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice.
    Hastings NB, Wang X, Song L, Butts BD, Grotz D, Hargreaves R, Fred Hess J, Hong KK, Huang CR, Hyde L, Laverty M, Lee J, Levitan D, Lu SX, Maguire M, Mahadomrongkul V, McEachern EJ, Ouyang X, Rosahl TW, Selnick H, Stanton M, Terracina G, Vocadlo DJ, Wang G, Duffy JL, Parker EM, Zhang L.
    Mol Neurodegener; 2017 May 18; 12(1):39. PubMed ID: 28521765
    [Abstract] [Full Text] [Related]

  • 17. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L, Egebjerg J, Barkholt P, Volbracht C.
    Brain Res; 2017 Jun 15; 1665():22-35. PubMed ID: 28411086
    [Abstract] [Full Text] [Related]

  • 18. Age-dependent impairment of memory and neurofibrillary tangle formation and clearance in a mouse model of tauopathy.
    Kubota T, Kirino Y.
    Brain Res; 2021 Aug 15; 1765():147496. PubMed ID: 33894222
    [Abstract] [Full Text] [Related]

  • 19. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
    Ishikawa A, Tokunaga M, Maeda J, Minamihisamatsu T, Shimojo M, Takuwa H, Ono M, Ni R, Hirano S, Kuwabara S, Ji B, Zhang MR, Aoki I, Suhara T, Higuchi M, Sahara N.
    J Alzheimers Dis; 2018 Aug 15; 61(3):1037-1052. PubMed ID: 29332041
    [Abstract] [Full Text] [Related]

  • 20. TOC1: a valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy.
    Ward SM, Himmelstein DS, Ren Y, Fu Y, Yu XW, Roberts K, Binder LI, Sahara N.
    Neurobiol Dis; 2014 Jul 15; 67():37-48. PubMed ID: 24631720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.